Back

Insulin-treated type 2 diabetes is associated with increased mortality after transvenous lead extraction for device infection: the IN2DEEP study

EP Europace Journal

3 July 2026
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Device Therapy

Contributors

Alessio Aloisio
Alessio Aloisio

Author

Alberto Spadotto
Alberto Spadotto

Author

Alma Mater Studiorum, University of Bologna Bologna , Italy

Giulia Massaro
Giulia Massaro

Author

Federico Vallisneri
Federico Vallisneri

Author

Laura Riccò
Laura Riccò

Author

Giulio Mancuso
Giulio Mancuso

Author

Cristian Martignani
Cristian Martignani

Author

Mauro Biffi
Mauro Biffi

Author

S. Orsola-Malpighi Policlinic Bologna , Italy

Matteo Ziacchi
Matteo Ziacchi

Author

IRCCS Sant'Orsola Polyclinic Bologna , Italy

Maria Carelli
Maria Carelli

Author

Igor Diemberger
Igor Diemberger

Author

You may be interested in
thumbnail
Congress Presentation
Early lead extraction and outcomes of cardiac implantable electronic device-related infective endocarditis
1 September 2025
thumbnail
Congress Presentation
Insulin treatment is associated with increased risk of device-treated ventricular tachyarrhythmia in patients with diabetes and heart failure
2 September 2019
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025
thumbnail
Congress Presentation
Advanced age and anticoagulation do not increase major complications during transvenous lead extraction: insights from 797 procedures
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources